Skip to main content
Clinical Trials/NCT03615417
NCT03615417
Completed
Not Applicable

Effectiveness of High-Flow Nasal Cannula (HFNC) Preoxygenation in Obese Patients Undergoing General Anesthesia: A Randomised Controlled Trial

Erasme University Hospital1 site in 1 country40 target enrollmentApril 19, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preoxygenation
Sponsor
Erasme University Hospital
Enrollment
40
Locations
1
Primary Endpoint
Functional Residual Capacity (FRC) variation
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study aims to evaluate the effectiveness of the High Flow Nasal Cannula (HFNC) for the preoxygenation of obese patients undergoing a general anesthesia. The HFNC interface is compared to a standard anesthesia FaceMask (FM) preoxygenation with Continuous Positive Airway Pressure (CPAP), the current gold standard procedure for obese induction.

The interest of HFNC preoxygenation is to increase the "safe apnea time" before critical arterial desaturation, useful in the management of difficult airways, especially in subjects with reduced respiratory reserves such as the obese.

Registry
clinicaltrials.gov
Start Date
April 19, 2018
End Date
September 7, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Erasme University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Francesco Ricottilli, MD

Resident, Department of Anesthesiology

Erasme University Hospital

Eligibility Criteria

Inclusion Criteria

  • Surgery with the need for general anesthesia with muscle relaxation
  • ASA (American Society of Anesthesiologists) physical status score II-III
  • BMI \> 35

Exclusion Criteria

  • Severe respiratory disease (acute respiratory failure, Chronic obstructive pulmonary disease COPD, parenchymal pneumopathies,...)
  • Severe nasal pathology (malformation, stenosis)
  • Criteria or previous difficult intubation
  • BMI \> 50
  • Chest circumference \> 150cm
  • Implanted electronic device (pacemaker, neurostimulator, ...)
  • Pregnancy

Outcomes

Primary Outcomes

Functional Residual Capacity (FRC) variation

Time Frame: 20 minutes

The difference of FRC, estimated by lung Electrical Impedance Tomography (EIT), during general anesthesia induction (from a base period to the mechanical ventilation).

Secondary Outcomes

  • Time of safe apnea(20 minutes)
  • Lowest SpO2(20 minutes)
  • Preoxygenation Comfort(6 hours)

Study Sites (1)

Loading locations...

Similar Trials